From the Institute for Stroke and Dementia Research (F.A.W., C.O., C.C., R.M., M. Duering, M.J.K., M. Dichgans), University Hospital, LMU Munich; Klinik für Neurologie (C.O.), SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany; Stroke Unit-Neurology Unit and Neuroradiology Unit (M.Z., R.P.), Arcispedale Santa Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS Reggio Emilia, Italy; Serviço de Neurologia (R.S., M.C.), Centro Hospitalar do Porto, Hospital de Santo António, Portugal; Hospital de la Santa Creu i Sant Pau (J.M.-F.), Biomedical Research Institute Sant Pau, IIB Sant Pau, Spain; Institut und Poliklinik für Neuroradiologie (J.L.), Universitätsklinikum Carl Gustav Carus, Dresden; Department of Neuroradiology (J.L.), Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich; Munich Cluster for Systems Neurology (SyNergy) (M. Dichgans); and German Center for Neurodegenerative Diseases (DZNE, Munich) (M. Dichgans), Germany.
Neurology. 2019 Feb 19;92(8):e792-e801. doi: 10.1212/WNL.0000000000006956. Epub 2019 Jan 23.
To investigate the prognostic relevance of cortical superficial siderosis (cSS) in patients with cerebral amyloid angiopathy (CAA).
A total of 302 patients fulfilling clinical and imaging criteria for probable or possible CAA were enrolled into a prospective, multicenter cohort study and followed for 12 months. cSS was assessed on T2*/susceptibility-weighted imaging MRI. The predefined primary composite endpoint was incident stroke or death in patients with cSS compared to those without. Secondary analyses included cerebrovascular events and functional outcome measured by the modified Rankin Scale (mRS). Multiple regression analysis was performed to adjust for possible confounders.
cSS prevalence was 40%. The primary endpoint occurred more frequently in patients with cSS (22%, 27/121) compared to those without (8%, 15/181, = 0.001). Rates of CAA-related incident intracranial hemorrhage were 17% (cSS) and 4% (no cSS, = 0.0003). The proportion of patients being functionally independent (mRS 0-2) 12 months from baseline were 59% (cSS) and 82% (no cSS, = 0.00002). Presence of cSS was associated with the primary endpoint (adjusted odds ratio [OR] 1.2, 95% confidence interval [CI] 1.1-1.3, = 0.0005), incident intracranial hemorrhage (adjusted OR 1.2, 95% CI 1.1-1.3, = 0.0003), and less favorable outcome as assessed by the mRS (common OR 1.9, 95% CI 1.2-3.1, = 0.009). Similar results were obtained in analyses restricted to patients with probable CAA and to patients with disseminated cSS (all < 0.005).
Patients with cSS and suspected CAA are at high risk for CAA-related incident intracranial hemorrhage and poor functional outcome. Both the presence and extent of cSS have prognostic relevance and may influence clinical decision-making.
探讨皮质浅表铁沉积(cSS)与脑淀粉样血管病(CAA)患者预后的相关性。
本前瞻性、多中心队列研究共纳入了 302 名符合临床和影像学标准的可能或很可能的 CAA 患者,并进行了 12 个月的随访。通过 T2* / 磁敏感加权成像 MRI 评估 cSS。预设的主要复合终点是 cSS 患者与无 cSS 患者相比,新发卒中或死亡的发生率。次要分析包括脑血管事件和改良 Rankin 量表(mRS)测量的功能结局。采用多元回归分析调整可能的混杂因素。
cSS 的患病率为 40%。cSS 患者(22%,27/121)主要终点的发生率高于无 cSS 患者(8%,15/181, = 0.001)。CAA 相关的颅内出血发生率分别为 17%(cSS)和 4%(无 cSS, = 0.0003)。从基线起 12 个月时,功能独立(mRS 0-2)的患者比例分别为 59%(cSS)和 82%(无 cSS, = 0.00002)。存在 cSS 与主要终点相关(调整后的优势比[OR] 1.2,95%置信区间[CI] 1.1-1.3, = 0.0005)、颅内出血事件(调整后的 OR 1.2,95% CI 1.1-1.3, = 0.0003)和 mRS 评估的预后较差(常见 OR 1.9,95% CI 1.2-3.1, = 0.009)。在限制为可能的 CAA 患者和弥漫性 cSS 患者的分析中,也得到了类似的结果(均 < 0.005)。
有 cSS 和可疑 CAA 的患者发生 CAA 相关的颅内出血和不良功能结局的风险很高。cSS 的存在和程度都具有预后相关性,并可能影响临床决策。